| Mrs Vanessa L Ailey, CNM | |
|
301 Med Tech Pkwy, Suite 200, Johnson City, TN 37604 | |
| (423) 794-1300 | |
| (423) 794-1820 |
| Full Name | Mrs Vanessa L Ailey |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 11 Years |
| Location | 301 Med Tech Pkwy, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265838650 | NPI | - | NPPES |
| Q024375 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 18851 (Tennessee) | Primary |
| 367A00000X | Advanced Practice Midwife | 19137 (South Carolina) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Franklin Healthcare Associates, Pllc | 2466346291 | 247 |
News Archive
A new clinical trial supports the benefits to people with osteoarthritis who used a unique extract of turmeric. Scientists in Italy have studied the pain-relief, increased flexibility, and other effects of a special, patented extract of the roots of turmeric, the flavorful spice that has been used for centuries as a traditional remedy. Turmeric formulations have shown a wide range of safety and significant scientific and clinical benefits in recent animal research and human clinical trials.
In a comprehensive review of recent randomized clinical trials and observational studies of diabetes and nutrition, Joslin Diabetes Center and Harvard School of Public Health investigators have identified specific foods and dietary patterns that are beneficial in preventing and controlling diabetes.
On February 6, the U.S. Food and Drug Administration began to enforce a previously-issued policy on unauthorized flavored cartridge-based e-cigarette products with the goal of addressing the current epidemic of youth use of e-cigarettes.
University of South Australia researchers are pioneering a new method to more accurately diagnose Parkinson's disease, a neurodegenerative brain disorder which affects around 70,000 Australians, resulting in a loss of control of body movements.
Repros Therapeutics (NasdaqGM:RPRX) today announced that on September 15, 2009, the Company received a second letter from The Nasdaq Stock Market advising that, in addition to the deficiencies previously disclosed on August 17, 2009, the Company's market value of publicly held shares was below the minimum $15,000,000 requirement for continued listing on the Nasdaq Global Market by Listing Rule 5450(b)(2)(C) or 5450(b)(3)(C).
› Verified 7 days ago
| Entity Name | State Of Franklin Healthcare Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063459410 PECOS PAC ID: 2466346291 Enrollment ID: O20040211001101 |
News Archive
A new clinical trial supports the benefits to people with osteoarthritis who used a unique extract of turmeric. Scientists in Italy have studied the pain-relief, increased flexibility, and other effects of a special, patented extract of the roots of turmeric, the flavorful spice that has been used for centuries as a traditional remedy. Turmeric formulations have shown a wide range of safety and significant scientific and clinical benefits in recent animal research and human clinical trials.
In a comprehensive review of recent randomized clinical trials and observational studies of diabetes and nutrition, Joslin Diabetes Center and Harvard School of Public Health investigators have identified specific foods and dietary patterns that are beneficial in preventing and controlling diabetes.
On February 6, the U.S. Food and Drug Administration began to enforce a previously-issued policy on unauthorized flavored cartridge-based e-cigarette products with the goal of addressing the current epidemic of youth use of e-cigarettes.
University of South Australia researchers are pioneering a new method to more accurately diagnose Parkinson's disease, a neurodegenerative brain disorder which affects around 70,000 Australians, resulting in a loss of control of body movements.
Repros Therapeutics (NasdaqGM:RPRX) today announced that on September 15, 2009, the Company received a second letter from The Nasdaq Stock Market advising that, in addition to the deficiencies previously disclosed on August 17, 2009, the Company's market value of publicly held shares was below the minimum $15,000,000 requirement for continued listing on the Nasdaq Global Market by Listing Rule 5450(b)(2)(C) or 5450(b)(3)(C).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Vanessa L Ailey, CNM Po Box 3889, Johnson City, TN 37602-3889 Ph: (423) 794-1300 | Mrs Vanessa L Ailey, CNM 301 Med Tech Pkwy, Suite 200, Johnson City, TN 37604 Ph: (423) 794-1300 |
News Archive
A new clinical trial supports the benefits to people with osteoarthritis who used a unique extract of turmeric. Scientists in Italy have studied the pain-relief, increased flexibility, and other effects of a special, patented extract of the roots of turmeric, the flavorful spice that has been used for centuries as a traditional remedy. Turmeric formulations have shown a wide range of safety and significant scientific and clinical benefits in recent animal research and human clinical trials.
In a comprehensive review of recent randomized clinical trials and observational studies of diabetes and nutrition, Joslin Diabetes Center and Harvard School of Public Health investigators have identified specific foods and dietary patterns that are beneficial in preventing and controlling diabetes.
On February 6, the U.S. Food and Drug Administration began to enforce a previously-issued policy on unauthorized flavored cartridge-based e-cigarette products with the goal of addressing the current epidemic of youth use of e-cigarettes.
University of South Australia researchers are pioneering a new method to more accurately diagnose Parkinson's disease, a neurodegenerative brain disorder which affects around 70,000 Australians, resulting in a loss of control of body movements.
Repros Therapeutics (NasdaqGM:RPRX) today announced that on September 15, 2009, the Company received a second letter from The Nasdaq Stock Market advising that, in addition to the deficiencies previously disclosed on August 17, 2009, the Company's market value of publicly held shares was below the minimum $15,000,000 requirement for continued listing on the Nasdaq Global Market by Listing Rule 5450(b)(2)(C) or 5450(b)(3)(C).
› Verified 7 days ago
Wendy N Rakestraw, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 301 Med Tech Pkwy Ste 200, Johnson City, TN 37604 Phone: 423-794-1300 Fax: 423-794-1820 |